SPY329.88+3.22 0.99%
DIA266.31+0.83 0.31%
IXIC11,187.94+183.07 1.66%

Morgan Stanley Maintains Overweight on Ultragenyx Pharmaceutical, Raises Price Target to $89

Morgan Stanley maintains Ultragenyx Pharmaceutical (NASDAQ:RARE) with a Overweight and raises the price target from $87 to $89.

· 10/13/2020 10:25
Morgan Stanley maintains Ultragenyx Pharmaceutical (NASDAQ:RARE) with a Overweight and raises the price target from $87 to $89.